Group 1 - Three companies, Jinxin Kangyang, Tianchen Biopharmaceuticals, and Hanfang Pharmaceutical, have submitted listing applications to the Hong Kong Stock Exchange, indicating strong interest in the healthcare sector [1] - Jinxin Kangyang focuses on providing integrated medical and elderly care services to the aging population in China [1] - Tianchen Biopharmaceuticals specializes in the discovery and development of biopharmaceuticals for allergic and autoimmune diseases [1] - Hanfang Pharmaceutical is engaged in the production, sales, and research of traditional Chinese medicine, particularly in treating skin and mucosal diseases [1] Group 2 - Hong Kong Exchanges and Clearing Limited reported a record revenue and other income of HKD 29.161 billion for 2025, a 30% year-on-year increase [2] - The increase in trading and settlement fees was driven by record trading volumes in the spot, derivatives, and commodities markets, with main business revenue rising by 32% [2] - Shareholder profit attributable reached HKD 17.754 billion, up 36% year-on-year, reflecting a robust trading environment [2] Group 3 - Trip.com Group reported a significant increase in net profit attributable to shareholders, rising by 95.08% year-on-year to HKD 33.294 billion for 2025 [3] - The group's net operating revenue was HKD 62.4 billion, a 17% increase compared to the previous year [3] - Basic earnings per share were HKD 0.5062, indicating strong financial performance despite management changes [3] Group 4 - Galaxy Entertainment reported a 13% year-on-year increase in net revenue, reaching HKD 49.2 billion for the year ending December 31, 2025 [4] - Adjusted EBITDA rose by 19% to HKD 14.5 billion, while profit attributable to shareholders increased by 22% to HKD 10.7 billion [4] - Basic earnings per share were HKD 2.44, benefiting from the recovery of the Macau tourism and gaming market [4]

Market Overview - On Thursday, the three major U.S. stock indices showed mixed performance, while the Hang Seng Index ADR rose, closing at 26,429.77 points, an increase of 48.75 points or 0.18% compared to the Hong Kong market close [1]. Company Performance - Major blue-chip stocks exhibited varied performance: HSBC Holdings closed at HKD 147.859, up 1.97% from the Hong Kong market close; Tencent Holdings closed at HKD 513.204, up 0.24% [3]. - Tencent Holdings reported a price of HKD 512.000, with a decline of 2.01%, while its ADR price was 513.204, reflecting a 0.24% increase [4]. - Alibaba Group's stock price was HKD 143.000, down 3.57%, with its ADR at 144.779, showing an increase of 1.779% [4]. - HSBC's stock price was HKD 145.000, up 1.61%, with its ADR at 147.859, reflecting a 1.97% increase [4]. - China Ping An's stock price decreased by 4.64% to HKD 67.850, while its ADR showed a slight increase of 0.49% [4]. - Meituan's stock price fell by 2.72% to HKD 80.450, with its ADR showing a minimal change of -0.03% [4].

Core Insights - Hong Kong Stock Exchange (HKEX) reported record high performance for the second consecutive year in 2025, with revenue and net profit reaching historical peaks, driven by record trading volumes in cash, derivatives, and commodity markets [1][2] Financial Performance - HKEX's revenue and other income for 2025 reached HKD 29.2 billion, a 30% year-on-year increase [1] - Shareholder profit attributable to the company was HKD 17.8 billion, reflecting a 36% year-on-year growth [1] - The board declared a second interim dividend of HKD 6.52 per share, alongside a first interim dividend of HKD 6 per share, totaling HKD 12.52 per share for the year, a 35% increase from the previous year [1] Market Dynamics - The strong rebound in the Hong Kong market is attributed to two main drivers: 1. Global capital seeking diversified allocations, with over 75% of trading volume in January coming from the mainland and Hong Kong markets combined [2] 2. The transformation of China's development model, emphasizing technological innovation, which has attracted numerous companies at the forefront of global tech innovation to HKEX [2] Future Outlook - HKEX aims to strengthen its connectivity with the mainland and expand its focus on broader Asian markets, responding to global investors' increasing demand for diverse investment tools beyond equities [2] - The exchange plans to invest long-term in various asset classes, including fixed income, commodities, and derivatives [2] IPO Regulations - In response to rumors about expanding the IPO confidentiality application scope to traditional industries, HKEX is considering various measures to enhance market attractiveness and competitiveness, including revising listing requirements for "same share, different rights" companies [4] - The "Tech Company Fast Track" launched in May 2025 has seen positive feedback, with over 100 biotech and tech companies currently in the queue for listing [4]

Core Insights - Hong Kong Exchanges and Clearing Limited (HKEX) reported record high financial results for the year 2025, with revenue and other income reaching HKD 29.2 billion, a 30% year-on-year increase, and net profit attributable to shareholders at HKD 17.8 billion, up 36% year-on-year [2] - The board declared a second interim dividend of HKD 6.52 per share, combined with the first interim dividend of HKD 6 per share, resulting in a total annual dividend of HKD 12.52 per share, reflecting a 35% increase year-on-year [2] Group 1: Financial Performance - HKEX achieved historical peaks in both revenue and net profit, driven by record trading volumes in spot, derivatives, and commodity markets [2] - The total market capitalization of HKEX is HKD 526.7 billion, with a share price of HKD 415.4 [7] Group 2: Market Dynamics - The strong rebound in the Hong Kong market is attributed to two main drivers: the global capital seeking diversified allocations and the transformation of China's development model [4] - In January, the combined trading volume of the mainland and Hong Kong markets accounted for over 75% of the total trading volume in the Asia-Pacific region [4] Group 3: Future Outlook - HKEX plans to strengthen its connectivity with the mainland and expand its focus on broader Asian markets, recognizing the growing demand for investment tools beyond equities [4] - The exchange is considering various measures to enhance market attractiveness and competitiveness, including potential expansions of the IPO confidentiality application scope and revisions to listing requirements [5][6]

来源：滚动播报 香港交易所26日公布的2025年全年业绩显示，全年收入及其他收益为291.61亿港元，同比增长30%。股 东应占溢利为177.54亿港元，同比上升36%。 业绩报告显示，2025年港交所的收入和其他收益及溢利连 续第二年创新高。由于现货、衍生产品及商品市场成交量创新高，港交所交易和结算费大幅增加，其主 要业务收入同比增长32%。 去年香港新股集资额位居全球第一。全年共有119只新股上市，总集资额达 2869亿港元，同比增加226%，其中两家新上市公司跻身2025年全球五大新股之列。2026年，新股上市 申请数目保持稳健，目前有逾400宗上市申请正在处理中。 港交所主席唐家成表示，尽管宏观环境持续 变化，港交所财务表现依然强劲，这主要受惠于国际和内地投资者对香港市场的兴趣和参与度持续增 加。展望将来，随着全球资本配置越趋多元化和亚洲经济影响力日益提升，全球集资市场格局正在迅速 改变，将为金融业带来许多新机遇。(新华社) ...

中新社香港2月26日电 (记者 戴小橦)香港交易及结算所有限公司(简称"港交所")26日发布2025年全年业 绩报告，期内录得收入及其他收益291.61亿港元，同比增长约30%；股东应占溢利177.54亿港元，同比 增长约36%。 财报显示，港交所2025年主要业务收入达271.03亿港元，同比上升约32%。业绩增长主要得益于现货、 衍生产品及商品市场成交量创新高，带动交易及结算费收入增加。 港交所行政总裁陈翊庭表示，2025年港交所充分发挥作为全球"超级联系人"的角色，重登全球新股融资 榜首，成交量及业绩均创新高。尽管预期今年市场波动仍将持续，但也看到一些值得乐观的因素，全球 投资者在寻求通过亚洲市场，尤其是中国资产，进行多元化配置和风险管理。 陈翊庭提到，港交所将于2026年第一季度，就"同股不同权"上市要求、优化首次公开招股(IPO)流程等 议题展开市场咨询，后续将继续围绕上市规则推进新的改革，涵盖上市门槛、招股流程、合规要求等多 个维度。(完) ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance relative to the market [6][4]. Core Insights - The company reported a total revenue of HKD 29.16 billion for 2025, reflecting a year-on-year growth of 30%. The main revenue component was HKD 27.11 billion, with a net profit of HKD 17.75 billion, marking a 36% increase year-on-year [4][6]. - The report highlights a significant increase in fee-related income, with various fee categories showing double-digit growth. Trading fees grew by 44%, and settlement and clearing fees increased by 49% [6][4]. - The report notes a decline in margin investment yields, with the weighted yield for margin financing at 1.31%, down from 1.51% in 2024 [6][4]. Financial Data and Earnings Forecast - The financial projections for the company are as follows: - Revenue for 2026 is estimated at HKD 28.32 billion, a decrease of 3% from 2025, with a net profit forecast of HKD 17.59 billion, a slight decline of 1% [5][7]. - The earnings per share (EPS) for 2026 is projected to be HKD 13.9, with a return on equity (ROE) of 29.8% [5][7]. - The report provides a detailed breakdown of revenue sources, with trading fees contributing 38%, settlement and clearing fees 26%, and investment income 19% [6][7]. Market Position and Trends - The Hong Kong stock market maintained its position as the global leader in IPO fundraising, with 119 new listings in 2025, raising HKD 286.9 billion, a 226% increase year-on-year [6][4]. - The report emphasizes the strong performance of the company's derivatives segment, with an average daily volume (ADV) of 166,000 contracts, a 7% increase year-on-year [6][4]. - The report also notes that the company is well-positioned to benefit from the ongoing deepening of connectivity between Hong Kong and mainland China, which is expected to enhance its market value [6][4].

Investment Rating - The report maintains a "Strong Buy" investment rating for Hong Kong Exchanges and Clearing Limited (00388.HK) [3][9]. Core Views - The company reported a record high total revenue of HKD 29.2 billion for the fiscal year 2025, representing a year-on-year increase of 30%. The net profit attributable to shareholders was HKD 17.8 billion, up 36% year-on-year, and EBITDA reached HKD 22.8 billion, reflecting a 40% increase year-on-year [1][9]. - The primary drivers of revenue growth were increased trading and settlement fees due to higher transaction volumes in the spot, derivatives, and commodities markets [9]. - The report highlights a significant increase in the number of IPOs and fundraising activities in the Hong Kong market, with 119 new listings in 2025 raising HKD 286.9 billion, more than three times the amount raised in 2024 [2][9]. Financial Performance - For the fiscal year 2025, the breakdown of revenue by segment includes: - Spot market: HKD 14.7 billion (+56% YoY) - Equity securities and financial derivatives: HKD 6.9 billion (+11% YoY) - Commodities: HKD 3.2 billion (+14% YoY) - Data and connectivity: HKD 2.2 billion (+7% YoY) - Company projects: HKD 2.2 billion (+17% YoY) [9]. - The EBITDA margin improved to 79%, an increase of 5 percentage points year-on-year, driven by strong performance in the spot and derivatives markets [9]. Market Dynamics - The average daily trading volume in the Hong Kong market increased by 90% year-on-year to HKD 249.8 billion, marking a 50% increase compared to the pre-pandemic high in 2021 [9]. - The report notes that the participation of international capital and increased engagement from southbound investors contributed to this growth [9]. Future Outlook - The report projects net profits for the company to be HKD 16.9 billion, HKD 17.7 billion, and HKD 18.6 billion for the years 2026 to 2028, respectively, with expected growth rates of -5%, +5%, and +5% [9]. - The target price is set based on a 40x PE ratio, indicating a potential upside of 37% from the current stock price of HKD 412.2 [9].

Group 1 - The Hong Kong Stock Exchange (HKEX) reported a record total revenue and other income of HKD 29.2 billion for the year 2025, a 30% increase from 2024, leading to a shareholder profit of HKD 17.8 billion, up 36% year-on-year [1] - In 2025, Hong Kong's IPO activity was particularly vibrant, with a total of 119 new listings raising HKD 286.9 billion, more than three times the amount raised in 2024, and two companies ranked among the top five globally for IPO fundraising [1] - The average daily trading volume for the Shanghai-Hong Kong Stock Connect reached RMB 212.4 billion in 2025, a 42% increase from 2024, while the average daily trading volume for the Hong Kong Stock Connect hit HKD 121.1 billion, up 151% year-on-year [1] Group 2 - The HKEX's CEO, Charles Li, noted that nearly half of the new IPOs in 2025 were companies expanding into international markets, attracting cornerstone investors from North America, Europe, the Middle East, and other regions [1] - The HKEX's "Tech Company" special line has gained popularity, with over 100 of the more than 400 companies currently in the queue being specifically served by this initiative [2] - The HKEX is considering expanding the scope of confidential IPO applications and will carefully evaluate various factors to enhance the competitiveness of the Hong Kong market [3]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The company reported a total revenue of HKD 29.16 billion for 2025, representing a year-on-year increase of 30%. The main revenue reached HKD 27.11 billion, up 32% year-on-year, while net profit was HKD 17.75 billion, reflecting a 36% increase year-on-year [4] - The report highlights significant growth in fee-related income, with various fee categories showing double-digit growth. Trading fees increased by 44%, settlement and clearing fees by 49%, and listing fees by 21% [6] - The Hong Kong stock market maintained its position as the global leader in IPO fundraising, with 119 new listings in 2025 and total IPO proceeds reaching HKD 286.9 billion, a 226% year-on-year increase [6] Financial Data and Earnings Forecast - The company’s projected financials for 2026E show a revenue of HKD 28.32 billion, a slight decrease of 3% year-on-year, with a net profit forecast of HKD 17.59 billion, down 1% year-on-year. The earnings per share (EPS) is expected to be HKD 13.9 [5][7] - The report provides a detailed breakdown of revenue sources for 2025, with trading fees contributing HKD 10.33 billion (38%), settlement and clearing fees HKD 7.04 billion (26%), and investment income HKD 5.11 billion (19%) [6][7] - The report anticipates a return on equity (ROE) of 29.8% for 2026E, with a price-to-earnings (PE) ratio of 29.7x, indicating that the stock is trading near historical lows [5][6]